156 related articles for article (PubMed ID: 18500267)
1. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation.
Karube K; Ying G; Tagawa H; Niino D; Aoki R; Kimura Y; Hashikawa K; Suefuji N; Sugita Y; Nomura Y; Shimizu K; Yoshida S; Seto M; Ohshima K
Mod Pathol; 2008 Aug; 21(8):973-8. PubMed ID: 18500267
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of
Kim M; Hwang HS; Son EM; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
Leuk Lymphoma; 2020 Dec; 61(14):3342-3350. PubMed ID: 32921221
[No Abstract] [Full Text] [Related]
3. Follicular lymphomas with plasmacytic differentiation include two subtypes.
Gradowski JF; Jaffe ES; Warnke RA; Pittaluga S; Surti U; Gole LA; Swerdlow SH
Mod Pathol; 2010 Jan; 23(1):71-9. PubMed ID: 19838161
[TBL] [Abstract][Full Text] [Related]
4. Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses.
Pan Y; Meng B; Sun B; Guan B; Liang Y; Wang H; Hao X; Fu K
Diagn Mol Pathol; 2012 Dec; 21(4):234-40. PubMed ID: 22968395
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
[TBL] [Abstract][Full Text] [Related]
7. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
[TBL] [Abstract][Full Text] [Related]
9. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.
Ikoma H; Miyaoka M; Hiraiwa S; Yukie Kikuti Y; Shiraiwa S; Hara R; Kojima M; Ohmachi K; Ando K; Carreras J; Nakamura N
Pathol Int; 2022 Jun; 72(6):321-331. PubMed ID: 35297566
[TBL] [Abstract][Full Text] [Related]
11. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
[TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive.
Bosga-Bouwer AG; van Imhoff GW; Boonstra R; van der Veen A; Haralambieva E; van den Berg A; de Jong B; Krause V; Palmer MC; Coupland R; Kluin PM; van den Berg E; Poppema S
Blood; 2003 Feb; 101(3):1149-54. PubMed ID: 12529293
[TBL] [Abstract][Full Text] [Related]
13. BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2.
Gollub W; Stassek B; Huckhagel T; Bernd HW; Krokowski M; Merz H; Feller AC; Thorns C
Anticancer Res; 2009 Nov; 29(11):4649-55. PubMed ID: 20032416
[TBL] [Abstract][Full Text] [Related]
14. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
[TBL] [Abstract][Full Text] [Related]
15. t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.
Gu K; Fu K; Jain S; Liu Z; Iqbal J; Li M; Sanger WG; Weisenburger DD; Greiner TC; Aoun P; Dave BJ; Chan WC
Mod Pathol; 2009 Sep; 22(9):1251-7. PubMed ID: 19465899
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
[TBL] [Abstract][Full Text] [Related]
17. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes.
Horsman DE; Okamoto I; Ludkovski O; Le N; Harder L; Gesk S; Siebert R; Chhanabhai M; Sehn L; Connors JM; Gascoyne RD
Br J Haematol; 2003 Feb; 120(3):424-33. PubMed ID: 12580956
[TBL] [Abstract][Full Text] [Related]
18. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours.
Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS
Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722
[TBL] [Abstract][Full Text] [Related]
19. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
Jardin F; Gaulard P; Buchonnet G; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Picquenot JM; Duval C; Parmentier F; Tilly H; Bastard C
Leukemia; 2002 Nov; 16(11):2309-17. PubMed ID: 12399977
[TBL] [Abstract][Full Text] [Related]
20. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
